Search

Search Constraints

You searched for: Author/Creator Azad, Nilofer

Search Results

1. 411 Novel intratumoral agent, INT230–6 induces cancer cell death, increases tumor infiltrates and results in durable benefit alone or in combination with pembrolizumab in refractory patients. (9th November 2020)

2. 411 Novel intratumoral agent, INT230–6 induces cancer cell death, increases tumor infiltrates and results in durable benefit alone or in combination with pembrolizumab in refractory patients. (9th November 2020)

3. A phase 1 trial of the oral DNA methyltransferase inhibitor CC‐486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors. Issue 16 (23rd April 2019)

4. ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer. (October 2015)

5. ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer. (October 2015)

6. ACR Appropriateness Criteria® Resectable Pancreatic Cancer. (April 2017)

7. Feasibility and safety of sequential research‐related tumor core biopsies in clinical trials1. Issue 7 (20th December 2012)

9. Intensity-Modulated Radiation Therapy for Rectal Carcinoma Can Reduce Treatment Breaks and Emergency Department Visits. (12th August 2012)

10. Intensity-Modulated Radiation Therapy for Rectal Carcinoma Can Reduce Treatment Breaks and Emergency Department Visits. (12th August 2012)